MX9701832A - Nuevos profarmacos para la terapia de tumores y enfermedades inflamatorias. - Google Patents
Nuevos profarmacos para la terapia de tumores y enfermedades inflamatorias.Info
- Publication number
- MX9701832A MX9701832A MX9701832A MX9701832A MX9701832A MX 9701832 A MX9701832 A MX 9701832A MX 9701832 A MX9701832 A MX 9701832A MX 9701832 A MX9701832 A MX 9701832A MX 9701832 A MX9701832 A MX 9701832A
- Authority
- MX
- Mexico
- Prior art keywords
- inflammatory diseases
- medicine
- tumor therapy
- new pro
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Abstract
Se describen compuestos de la formula (I) Glicosil-Y[-C(=Y)-X-]p-W(R)n-Z-C(+Y)-sustancia activa (I) que se adecuan para el tratamiento de enfermedades cancerosas, enfermedades autoinmunes y enfermedades inflamatorias cronicas tales como artritis reumatoidea.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96103866.8 | 1996-03-12 | ||
| EP96103866 | 1996-03-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9701832A true MX9701832A (es) | 1998-07-31 |
| MXPA97001832A MXPA97001832A (es) | 1998-11-09 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1157041E (pt) | Anticorpos para terapia e diagnostico de cancro | |
| BR9908823A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
| DE69830072D1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
| ES2141128T3 (es) | Combinacion de agentes anti-hormonales y moleculas de fijacion. | |
| BG101284A (en) | Compounds and methods for cancer treatment | |
| NZ500657A (en) | Interleukin-3 gene therapy for cancer | |
| MY136095A (en) | Use of human anti-ctla-4 antibodies for treatment of cancer | |
| GEP20094798B (en) | (s,s)-reboxetine for treating chronic pain | |
| MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
| BR9701248A (pt) | Novos pró-medicamentos para a terapia de tumores e distúrbios inflamatórios | |
| ATE399560T1 (de) | Pharmazeutische zusammensetzungen enthaltend arsentrioxid zur behandlung von nicht-hodgkihn- lymphome | |
| MXPA04003674A (es) | Uso mejorado de compuesto antitumoral en terapia de cancer. | |
| MX9707022A (es) | Derivados de fenilo trisustituidos. | |
| TR199800270T1 (xx) | Kanser hastal�klar�n�n ilerlemesini �nlemede flukonazol kullan�m�. | |
| IL146125A0 (en) | Novel quinones as disease therapies | |
| CA2234263A1 (fr) | Composition pharmaceutique contre les tumeurs et infections a papillomavirus | |
| IL128610A0 (en) | Cryptophycin compounds | |
| IL141550A0 (en) | Methods and compositions for the prevention or treatment of cancer | |
| WO2004047757A3 (en) | Diagnosing and treating hematopoietic cancers | |
| AU5302599A (en) | Method for diagnosing bone metastasis of malignant tumor | |
| BR0212446A (pt) | Uso de 4-piridilmetilftalazinas para tratamento de câncer | |
| GR880100589A (en) | Metalloporfyrines for the inversion of the toxic activity for the tumors treatment | |
| WO2000037065A3 (en) | Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs | |
| MX9706086A (es) | Preparaciones farmaceuticas para inhibicion de tnf. | |
| ZA981558B (en) | Inclusion complexes in aqueous solution |